acut
respiratori
infect
ari
respons
elev
childhood
morbid
mortal
account
approxim
four
million
death
among
children
age
younger
year
result
substanti
burden
healthcar
develop
countri
ari
account
death
among
children
age
younger
year
disabl
prematur
therefor
data
epidemiolog
season
ari
import
develop
control
prevent
niger
estim
mortal
rate
among
children
age
younger
year
per
unicef
child
mortal
estim
death
associ
malaria
respiratori
infect
diarrhea
accord
niger
health
statist
yearbook
estim
case
fatal
proport
associ
respiratori
infect
absenc
laboratori
diagnosi
difficult
clinic
differenti
caus
pathogen
due
similar
main
caus
agent
ari
virus
major
virus
includ
respiratori
syncyti
viru
rsv
human
rhinoviru
hrv
influenza
viru
inf
type
b
human
adenoviru
hav
human
parainfluenza
viru
hpiv
human
metapneumoviru
hmpv
human
coronaviru
hcov
major
bacteri
pathogen
includ
streptococcu
pneumonia
staphylococcu
aureu
haemophilu
influenza
niger
scarciti
data
ari
although
routin
influenza
surveil
system
exist
inf
detect
sampl
children
age
younger
year
hospit
sever
acut
respiratori
ill
sari
knowledg
etiolog
ari
niger
could
inform
select
import
pathogen
includ
routin
surveil
improv
clinic
manag
patient
studi
aim
describ
viral
bacteri
infect
among
children
age
younger
year
hospit
febril
ari
two
nation
hospit
niamey
capit
citi
niger
report
clinic
procedur
conduct
prospect
studi
among
children
age
younger
year
hospit
febril
ari
januari
decemb
niger
four
distinct
season
categor
nation
director
meteorolog
cold
season
dri
season
may
raini
season
june
septemb
hot
season
octob
studi
part
total
niger
infect
respiratoir
tonira
project
fund
total
corpor
foundat
order
strengthen
medic
care
febril
ari
among
children
age
younger
year
studi
conduct
pediatr
ward
two
nation
tertiari
hospit
situat
niamey
name
nation
de
niamey
hnn
nation
hnl
two
hospit
provid
gener
health
care
popul
niamey
estim
million
well
patient
refer
across
countri
laboratori
detect
respiratori
virus
bacteria
conduct
centr
de
recherch
et
sanitair
cerm
niamey
niger
nation
refer
laboratori
influenza
demograph
clinic
data
well
use
antibiot
admiss
collect
use
standard
data
collect
form
malaria
test
implement
site
use
thick
blood
film
microscopi
chest
perform
discret
attend
physician
typic
abnorm
radiolog
find
assess
includ
pulmonari
opac
acut
bronchiol
enlarg
intercost
space
malnutrit
determin
use
ratio
weight
height
level
classifi
moder
sever
attend
physician
use
nation
standard
base
technic
guidelin
integr
diseas
surveil
respons
african
region
retriev
http
febril
ari
conjunct
malaria
malnutrit
diarrhea
assess
admiss
use
standard
case
investig
form
outcom
ie
discharg
referr
death
record
enrol
patient
febril
ari
case
defin
hospit
child
age
younger
year
onset
fever
higher
cough
within
day
prior
admiss
least
one
follow
sign
inabl
drink
breastfe
lethargi
vomit
convuls
nasal
flare
chest
indraw
stridor
calm
child
tachypnea
nasopharyng
swab
collect
enrol
patient
place
univers
transport
medium
store
transport
cerm
within
hour
collect
test
respiratori
sampl
test
inf
type
b
hpiv
type
hcov
hmpv
b
rsv
b
human
parechoviru
hpv
human
enteroviru
hev
hav
human
bocaviru
hbov
hrv
pneumonia
h
influenza
type
b
hib
aureu
mycoplasma
pneumonia
chlamydia
pneumonia
use
fast
track
diagnost
respiratori
pathogen
plu
kit
catalog
ftd
follow
manufactur
instruct
intern
control
provid
part
kit
use
monitor
sampl
extract
revers
transcript
perform
use
ftd
respiratori
pathogen
plu
kit
follow
reaction
volum
test
consist
nucleic
acid
bufferenzym
mix
kit
ambion
life
technolog
usa
catalog
number
amplif
perform
use
abi
fast
pcr
system
thermocycl
appli
biosystem
usa
follow
cycl
condit
use
minut
revers
transcript
minut
enzym
activ
cycl
second
second
amplif
fluoresc
assess
amplif
step
posit
neg
viru
plasmid
control
provid
kit
includ
run
monitor
assay
viral
andor
bacteri
detect
report
percentag
posit
overal
within
select
categori
eg
age
group
season
children
age
younger
year
stratifi
two
age
group
infant
age
younger
year
young
children
age
year
compar
studi
addit
major
enrol
children
age
younger
year
hinder
abil
categor
age
smaller
age
group
stata
version
statacorp
colleg
station
texa
usa
use
analysi
protocol
approv
nation
ethic
consult
committe
ccne
niger
clinic
research
committe
corc
institut
pasteur
pari
proxi
inform
consent
obtain
parent
legal
guardian
children
children
meet
case
definit
verbal
consent
obtain
includ
studi
januari
decemb
enrol
test
children
age
younger
year
age
younger
year
male
admit
hnn
comorbid
investig
malaria
malnutrit
diarrhea
diagnos
case
patient
respect
malnourish
children
identifi
sever
malnutrit
tabl
chest
perform
case
patient
patient
abnorm
radiolog
find
common
pulmonari
opac
extens
intercost
space
bronchiol
one
hundr
children
receiv
antibiot
treatment
within
day
prior
admiss
children
prescrib
antibiot
treatment
admiss
case
fatal
proport
overal
among
children
age
younger
year
respect
overal
specimen
test
posit
least
one
respiratori
viru
bacterium
tabl
posit
specimen
test
posit
respiratori
virus
test
posit
respiratori
bacteria
test
posit
respiratori
virus
bacteria
singl
viru
bacterium
detect
posit
specimen
singl
viral
infect
figur
number
viral
andor
bacteri
detect
among
posit
specimen
rang
antibiot
prescrib
patient
viral
bacteri
viral
bacteri
detect
respect
overal
respiratori
virus
detect
specimen
rsv
hpiv
type
hrv
hav
inf
predomin
virus
detect
tabl
specimen
commonli
detect
one
wherea
inf
type
predomin
among
specimen
hcov
detect
specimen
mostli
detect
one
hmpv
hbov
hev
detect
individu
less
specimen
hpv
least
commonli
detect
respiratori
viru
specimen
test
posit
least
one
respiratori
viru
two
respiratori
virus
detect
specimen
dual
detect
occur
specimen
rsv
hmpv
inf
mostli
detect
specimen
singl
viral
infect
wherea
hpv
hev
hav
hbov
hrv
mostli
detect
specimen
two
viral
infect
figur
number
viral
detect
among
specimen
rang
among
patient
abnorm
radiolog
find
respiratori
virus
commonli
detect
among
patient
bronchiol
rsv
hpiv
mostli
detect
among
children
age
younger
compar
year
tabl
regard
season
inf
mostli
detect
cold
season
hpiv
hcov
mostli
detect
dri
season
hrv
mostli
detect
raini
season
rsv
hmpv
mostli
detect
hot
season
tabl
figur
overal
respiratori
bacteria
detect
specimen
pneumonia
frequent
detect
bacterium
follow
aureu
hib
tabl
pneumonia
c
pneumonia
detect
individu
less
specimen
specimen
test
posit
least
one
respiratori
bacteria
two
respiratori
bacteria
detect
specimen
dual
detect
occur
specimen
pneumonia
mostli
detect
specimen
singl
bacteri
infect
wherea
hib
aureu
mostli
detect
specimen
two
bacteri
infect
figur
number
bacteri
detect
among
specimen
rang
among
patient
abnorm
radiolog
find
respiratori
bacteria
commonli
detect
among
patient
pulmonari
opac
pneumonia
aureu
mostli
detect
raini
season
june
septemb
tabl
figur
report
detect
respiratori
virus
bacteria
among
children
age
younger
year
hospit
febril
ari
niger
januari
decemb
least
one
respiratori
viru
bacteria
found
sampl
test
proport
similar
report
previou
studi
etiolog
ari
children
age
younger
year
niger
although
limit
number
find
also
consist
similar
studi
conduct
africa
rang
asia
rang
posit
proport
respiratori
virus
vari
consider
rsv
hpiv
hrv
hav
inf
commonli
detect
virus
report
studi
rsv
inf
hmpv
mostli
detect
singl
viral
rsv
hrv
hpiv
also
predomin
virus
detect
children
age
younger
year
previou
studi
conduct
rsv
consid
major
caus
ari
children
age
younger
commonli
detect
viru
also
studi
among
case
hpiv
hcov
detect
hpiv
type
hcov
type
predomin
type
consist
previou
studi
inf
detect
case
agreement
find
nation
influenza
relat
studi
africa
among
patient
hospit
higher
influenza
posit
proport
report
among
outpati
studi
period
respiratori
virus
detect
throughout
four
howev
rsv
mostli
detect
hot
dri
season
higher
temperatur
lower
rel
wherea
inf
mostli
detect
cold
raini
season
report
influenza
sentinel
surveil
season
pattern
confirm
multiyear
studi
could
use
epidem
prepared
respons
plan
high
colon
rate
pneumonia
aureu
hib
report
children
fraction
colon
event
report
result
pneumonia
detect
specimen
bacteria
predominantli
detect
sampl
howev
colon
rate
found
studi
lower
report
studi
conduct
could
attribut
introduct
pneumococc
conjug
vaccin
niger
low
detect
rate
hib
may
also
attribut
introduct
hib
conjug
tetanu
toxoid
vaccin
expand
immun
program
uncommon
respiratori
bacteri
pathogen
includ
pneumonia
c
pneumonia
detect
low
rate
less
correl
result
report
previou
studi
children
alreadi
receiv
antibiot
hospit
nearli
children
receiv
antibiot
admiss
find
consist
studi
mali
report
rate
antibiot
uptak
admiss
elev
antibiot
usag
nation
guidelin
ari
treatment
base
integr
manag
childhood
ill
manuel
sur
la
prise
en
charg
de
maladi
de
lenfant
pcime
retriev
http
includ
systemat
use
antibiot
empir
treatment
prevent
superinfect
howev
consid
high
number
patient
respiratori
virus
detect
practic
rais
concern
potenti
excess
use
resist
patient
febril
ari
also
diarrhea
malnourish
coinfect
malaria
could
explain
fact
infect
constitut
lead
public
health
concern
niger
respons
elev
childhood
mortal
annuair
de
statistiqu
sanitair
du
niger
retriev
http
studi
present
limit
first
studi
span
period
month
limit
abil
fulli
assess
tempor
circul
pattern
investig
agent
due
small
sampl
size
may
also
underpow
detect
small
variat
tempor
distribut
investig
agent
second
attribut
causal
remain
challeng
due
lack
control
studi
associ
pathogen
detect
ill
could
well
assess
although
viral
bacteri
pathogen
identifi
studi
describ
previou
case
control
studi
caus
agent
addit
collect
blood
sampl
assess
whether
detect
common
bacteri
colon
nasopharynx
pneumonia
associ
invas
diseas
third
record
number
patient
febril
ari
refus
enrol
hinder
abil
estim
underenrol
last
given
patient
febril
ari
enrol
could
result
underestim
rsv
burden
sinc
larg
proport
ill
associ
prospect
studi
viral
bacteri
pathogen
detect
high
proport
among
hospit
children
age
younger
year
febril
ari
niamey
niger
howev
investig
carri
assess
risk
factor
associ
pathogen
ill
although
nation
guidelin
ari
treatment
recommend
systemat
empir
antibiot
therapi
result
suggest
antibiot
use
might
unnecessari
case
given
predomin
viral
infect
potenti
caus
febril
ari
furthermor
predispos
diseas
malaria
malnutrit
diarrhea
may
contributori
factor
febril
ari
exacerb
among
hospit
children
conceptu
adam
lagar
sani
ousman
ibrahim
dan
dano
halima
boubacar
mainassara
jean
testa
saidou
mamad
fund
acquisit
adam
lagar
sani
ousman
jean
testa
saidou
mamad
investig
adam
lagar
sani
ousman
ibrahim
dan
dano
bassira
issaka
idi
issa
halima
boubacar
mainassara
jean
testa
stefano
tempia
saidou
mamad
project
administr
adam
lagar
sani
ousman
jean
testa
visual
adam
lagar
saidou
mamad
write
origin
draft
prepar
adam
lagar
sani
ousman
jean
testa
stefano
tempia
saidou
mamad
write
review
edit
adam
lagar
sani
ousman
ibrahim
dan
dano
bassira
issaka
idi
issa
halima
boubacar
mainassara
jean
testa
stefano
tempia
saidou
mamad
author
read
approv
final
version
manuscript
adam
lagar
full
access
data
take
respons
integr
data
accuraci
data
analysi
lead
authormanuscript
guarantor
adam
lagar
affirm
manuscript
honest
accur
transpar
account
studi
report
import
aspect
studi
omit
discrep
studi
plan
relev
regist
explain
author
declar
commerci
associ
may
pose
conflict
interest
find
conclus
report
author
necessarili
repres
offici
posit
us
center
diseas
control
prevent
usa
